CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients
ACS Sensors · 24.10.2025 · 10 (10) · 7388-7402
DOI: 10.1021/acssensors.5c01152 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 09.10.2025. Verfasst von Bingjie Zeng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, B7-H1 Antigen, Neoplastic Cells, Circulating, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanghai Chest Hospital, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
- College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
ORCID-Profile: Lifang Ma
Förderung
- Shanghai Chest Hospital
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zeng, B., Sheng, A., Zhang, X., Wang, X., Bao, Y., Huang, Y., Huang, Y., Shan, L., Xu, X., Qin, Y., Yang, Y., Deng, Y., Tian, L., Wang, J., & Ma, L. (2025). CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients. ACS Sensors, 10(10), 7388-7402. https://doi.org/10.1021/acssensors.5c01152
Vancouver
Zeng B, Sheng A, Zhang X, Wang X, Bao Y, Huang Y, et al. CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients. ACS Sensors. 2025;10(10):7388-7402. doi:10.1021/acssensors.5c01152
BibTeX
@article{Zeng2025,
author = {Zeng, Bingjie and Sheng, Anzhi and Zhang, Xiao and Wang, Xianzhao and Bao, Yunxia and Huang, Yiwen and Huang, Yiman and Shan, Liang and Xu, Xin and Qin, Yueyang and Yang, Yiran and Deng, Yiran and Tian, Ling and Wang, Jiayi and Ma, Lifang},
title = {CRISPR/Cas12a Integrated with a Microfluidic System Enhanced Analysis of Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells from Non-Small Cell Lung Cancer Patients},
journal = {ACS Sensors},
year = {2025},
volume = {10},
number = {10},
pages = {7388--7402},
doi = {10.1021/acssensors.5c01152}
}
EUVIMED